| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Ying-Ying Xu | |
| Xin-Jun Cai | |||
| P2860 | cites work | Micro- and nanoparticles--medical applications. | Q37700394 |
| Potential of nanoparticulate drug delivery systems by intranasal administration. | Q37704495 | ||
| Viral vectors for gene transfer: current status of gene therapeutics | Q37706296 | ||
| Nanotechnology platforms in diagnosis and treatment of primary brain tumors | Q37736525 | ||
| Molecular self-assembly and applications of designer peptide amphiphiles | Q37760440 | ||
| Using Self-Assembled Nanomaterials to Inhibit the Formation of Metastatic Cancer Stem Cell Colonies in Vitro | Q39649098 | ||
| Nano hemostat solution: immediate hemostasis at the nanoscale. | Q40243410 | ||
| Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. | Q43012213 | ||
| Formulation and characterization of nanoemulsion of olanzapine for intranasal delivery | Q43156729 | ||
| Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses | Q43225836 | ||
| Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium | Q48568227 | ||
| Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold. | Q50659784 | ||
| Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device. | Q51084047 | ||
| [Prospects for targeted therapy for gliomas]. | Q55465070 | ||
| Biovector nanoparticles improve antinociceptive efficacy of nasal morphine | Q58854577 | ||
| Poly(alkycyanoacrylate) nanoparticles for enhanced delivery of therapeutics – is there real potential? | Q59234888 | ||
| Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? | Q24599399 | ||
| Translocation of Inhaled Ultrafine Particles to the Brain | Q29547870 | ||
| Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. | Q30476979 | ||
| Magnetic nanoparticles for drug delivery applications | Q33389114 | ||
| Novel nanomaterials for clinical neuroscience | Q34009532 | ||
| Potential of solid lipid nanoparticles in brain targeting | Q34010210 | ||
| Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. | Q34506249 | ||
| Potential new methods for antiepileptic drug delivery | Q34769911 | ||
| Peptide-directed self-assembly of hydrogels | Q34865898 | ||
| Getting into the brain: approaches to enhance brain drug delivery | Q34897833 | ||
| Gene delivery to the eye using adeno-associated viral vectors | Q34987213 | ||
| Adeno-associated viral vectors for retinal gene transfer. | Q35566831 | ||
| Non-primate lentiviral vectors | Q35577208 | ||
| Gene therapy of retinal dystrophies: achievements, challenges and prospects. | Q35642408 | ||
| Multi-component extracellular matrices based on peptide self-assembly | Q36070639 | ||
| Nanotechnology-based drug delivery systems | Q36419770 | ||
| Versatility of AAV vectors for retinal gene transfer | Q36965152 | ||
| Adeno-associated viral vectors and the retina | Q37055045 | ||
| Colloidosomes: an emerging vesicular system in drug delivery | Q37058065 | ||
| Polymeric nanoparticles for the drug delivery to the central nervous system | Q37076360 | ||
| Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery | Q37121790 | ||
| AAV-mediated gene therapy for retinal disorders: from mouse to man. | Q37140652 | ||
| Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting | Q37182367 | ||
| Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain | Q37387616 | ||
| Gene therapy in large animal models of human cardiovascular genetic disease | Q37416912 | ||
| Lipid nanocapsules: a new platform for nanomedicine | Q37466945 | ||
| Recent advances in the use of cell-penetrating peptides for medical and biological applications | Q37524585 | ||
| Nanoparticles for direct nose-to-brain delivery of drugs. | Q37531152 | ||
| Colloidal polymeric nanoparticles and brain drug delivery | Q37551977 | ||
| Uses of nanoparticles for central nervous system imaging and therapy | Q37555829 | ||
| Nanotechnology applications for improved delivery of antiretroviral drugs to the brain | Q37633076 | ||
| Lipid nanoparticles for drug delivery to the brain: in vivo veritas. | Q37670020 | ||
| Advances in the treatment of neurodegenerative disorders employing nanotechnology | Q37690357 | ||
| P433 | issue | 4 | |
| P921 | main subject | nanomaterial | Q967847 |
| P304 | page(s) | 319-323 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Cytotechnology | Q15752151 |
| P1476 | title | Nanomaterials in controlled drug release | |
| P478 | volume | 63 |
| Q35761204 | Apoptosis of Hepatocellular Carcinoma Cells Induced by Nanoencapsulated Polysaccharides Extracted from Antrodia Camphorata |
| Q28387046 | Health risk assessments of lithium titanate nanoparticles in rat liver cell model for its safe applications in nanopharmacology and nanomedicine |
Search more.